Prelude Therapeutics Inc
(NAS:PRLD)
$
1.06
-0.08 (-7.02%)
Market Cap: 58.34 Mil
Enterprise Value: -77.15 Mil
PE Ratio: 0
PB Ratio: 0.37
GF Score: 23/100 
Prelude Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 12, 2021 / 09:00PM GMT
Release Date Price:
$44.3
(+7.58%)
Tazeen Ahmad
BofA Securities, Research Division - VP
Okay, everybody, good afternoon. Thanks for sticking around to see our afternoon sessions of the BofA Healthcare Conference.
It's my pleasure to have my next presenting company, Prelude. Presenting for Prelude today are several members of the management team, including Kris Vaddi, Christopher Pierce, as well as Brian Piper. Gentlemen, good afternoon. Thank you so much for joining us.
Brian D. Piper
Prelude Therapeutics Incorporated - CFO
Good afternoon, Tazeen. Thanks for having us.
Christopher Pierce
Prelude Therapeutics Incorporated - Executive VP & Chief of Business Operations
Thanks very much, Tazeen.
Krishna Vaddi
Prelude Therapeutics Incorporated - Founder, CEO & Director
Thank you, and good afternoon, and thanks for the opportunity to participate in the conference.
Tazeen Ahmad
BofA Securities, Research Division - VP
Of course, so Kris, maybe
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers